Latest News
- November 18, 2025ANDA application for Bimatoprost ophthalmic solution received Marketing Authorization from the USFDA!
- November 12, 2025ANDA application for Risperidone extended-release injectable suspension has received Marketing Authorization from the USFDA!
- October 30, 2025Accelerating Clinical Research!
- September 12, 2025Join CBCC at CPHI Frankfurt 2025
- August 08, 2025International Publication of Phase II clinical Trial
August 09, 2022
Successful USFDA inspection at site
CBCC Global Research is proud to announce the successful completion of USFDA inspection for oncology PKBE study with “ZERO 483” at Bangalore site.
#USFDA #Inspection #CBCC #Oncology #ANDA #Quality #Compliance